← Retour à la listeCompanyIncheon Startup Park is the first space in Korea where the public and private sectors collaborate to nurture startups. It consists of InSta I, operated by a public institution (Incheon Technopark), and InSta II, operated by a private company (Shinhan Financial Group). Here, we introduce the representative resident companies of InSta I.
These startups have been recognized for the future value of their products and the potentiel de croissance of their companies, having been selected for Korea's highest-level startup preferential programs, and they are spreading their wings wide to leap toward becoming 'unicorn companies' — startups valued at over USD 1 billion.
RudaCure Inc. (PDG Yongho Kim), which leverages basic biomedical research to present a new paradigm in développement de nouveaux médicaments capable of achieving fundamental treatment for intractable conditions, is working on developing a traitement de la sécheresse oculaire without effets secondaires and a non-addictive traitement de la douleur.
Focusing on the market for age-related eye diseases, l'entreprise has gained attention for developing and patenting eye drops for treating ocular conditions tels que sécheresse oculaire. ← Retour à la liste
Qui sera la future licorne ? L'Incheon Startup Park trace la voie
2021-07-16
These startups have been recognized for the future value of their products and the potentiel de croissance of their companies, having been selected for Korea's highest-level startup preferential programs, and they are spreading their wings wide to leap toward becoming 'unicorn companies' — startups valued at over USD 1 billion.
RudaCure Inc. (PDG Yongho Kim), which leverages basic biomedical research to present a new paradigm in développement de nouveaux médicaments capable of achieving fundamental treatment for intractable conditions, is working on developing a traitement de la sécheresse oculaire without effets secondaires and a non-addictive traitement de la douleur.
Focusing on the market for age-related eye diseases, l'entreprise has gained attention for developing and patenting eye drops for treating ocular conditions tels que sécheresse oculaire.